Increasing utilisation of intravenous iron among Australian women of reproductive age, 2013-2024: an Australian population-based study [0.03%]
2013-2024年澳大利亚育龄女性静脉注射铁剂使用量增加的流行病学研究
Gizat M Kassie,Hannah Jackson,Lisa Clarke et al.
Gizat M Kassie et al.
Background: Utilisation of intravenous iron is increasingly recognised as a viable option for treating iron deficiency, especially when oral iron is ineffective or intolerable. However, there are no updated data on the lo...
Australasian chronic lymphocytic leukaemia consensus statement: 2026 update [0.03%]
澳新慢性淋巴细胞性白血病共识声明：2026年更新版
Sean McKeague,Joanna Katarzyna Czerwinski,Xavier Badoux et al.
Sean McKeague et al.
In 2023, a consensus statement on the diagnosis and management of chronic lymphocytic leukaemia (CLL) in Australasia was published. Since then, advances in clinical evidence and increased availability of molecular diagnostics and targeted t...
Paul A Komesaroff
Paul A Komesaroff
Editorial
Internal medicine journal. 2026 Jul 2. DOI:10.1111/imj.70496 2026
Zhan Su,Jie Xu,Hongqing Cui
Zhan Su
Crossover effect: causal machine learning reveals opposing mortality responses to mean arterial pressure targets among phenotypically distinct hypertensive patients with septic shock [0.03%]
跨界效应：因果机器学习揭示了表型不同的高血压患者在平均动脉压目标中的相反的死亡率反应
Zekai Yu
Zekai Yu
Aims: To quantify the heterogeneity of treatment effects of higher versus standard MAP targets on 28-day mortality, to identify distinct clinical phenotypes that respond differentially to MAP targets, and to derive simple...
Clinicopathological findings, correlations and outcomes in patients with renal disease and living with antiretroviral-treated human immunodeficiency virus infection [0.03%]
接受抗逆转录病毒治疗的人类免疫缺陷病毒感染患者的肾脏疾病临床病理学发现、相关性及转归分析
Jacqueline A Evans,Christopher S B Sia,Gopal Basu et al.
Jacqueline A Evans et al.
Background and aims: Antiretroviral therapy (ART) has modified the incidence of renal complications and the patterns of renal disease in people living with Human Immunodeficiency Virus (PLWH). We reviewed (2011-2021) the ...
Approach to thyroid disorders associated with immune checkpoint inhibitors and tyrosine kinase inhibitors [0.03%]
免疫检查点抑制剂和酪氨酸激酶抑制剂相关甲状腺疾病的处理方法
Vaishali Padhye,Jui Ho
Vaishali Padhye
Immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs) have revolutionised the therapeutic landscape for a range of malignancies. However, their use is frequently associated with immune-related adverse events (irAEs), par...
Destiny O&#x;Dea,Andrew Siyoung Chung,Arunima Jain et al.
Destiny O&#x;Dea et al.
Background: Hypertension is an important preventable risk factor for cardiovascular and kidney disease, with limited data regarding the impact on blood pressure (BP) control following management in specialist hypertension...
Thirty-day mortality among patients admitted due to acute myocardial infarction during the dates of the Cardiac Society of Australia and New Zealand Annual Scientific Meeting [0.03%]
澳大利亚和新西兰心脏科学年会期间因急性心肌梗死住院患者的30天死亡率
Timothy Nathan Kwan,Richa Malhotra,David Brieger et al.
Timothy Nathan Kwan et al.
Patients admitted during major medical conferences may receive different care if there are significant staff shortages. We evaluated the mortality of patients presenting with acute myocardial infarction (AMI) according to whether they were ...
Albert S Kim,Christian M Girgis
Albert S Kim
Denosumab is a highly effective therapy for osteoporosis. Since its approval by the Therapeutic Goods Administration (TGA) in 2010, use of denosumab has surged across Australia, delivering substantial fracture-prevention benefits to tens of...